Bath & Body Works (NYSE:BBWI – Get Free Report) and Uxin (NASDAQ:UXIN – Get Free Report) are both consumer discretionary companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, analyst recommendations, earnings, risk, dividends, profitability and institutional ownership.
Analyst Recommendations
This is a summary of current recommendations and price targets for Bath & Body Works and Uxin, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Bath & Body Works | 1 | 15 | 4 | 0 | 2.15 |
| Uxin | 1 | 0 | 1 | 0 | 2.00 |
Bath & Body Works presently has a consensus price target of $22.20, indicating a potential upside of 4.26%. Uxin has a consensus price target of $4.50, indicating a potential upside of 456.24%. Given Uxin’s higher probable upside, analysts plainly believe Uxin is more favorable than Bath & Body Works.
Institutional & Insider Ownership
95.1% of Bath & Body Works shares are held by institutional investors. Comparatively, 22.4% of Uxin shares are held by institutional investors. 0.3% of Bath & Body Works shares are held by company insiders. Comparatively, 62.9% of Uxin shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Risk and Volatility
Bath & Body Works has a beta of 1.31, meaning that its stock price is 31% more volatile than the S&P 500. Comparatively, Uxin has a beta of 0.87, meaning that its stock price is 13% less volatile than the S&P 500.
Profitability
This table compares Bath & Body Works and Uxin’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Bath & Body Works | 10.83% | -53.48% | 13.40% |
| Uxin | -10.10% | N/A | -16.37% |
Earnings and Valuation
This table compares Bath & Body Works and Uxin”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Bath & Body Works | $7.29 billion | 0.59 | $649.00 million | $3.84 | 5.54 |
| Uxin | $463.27 million | 0.38 | -$39.69 million | ($0.28) | -2.89 |
Bath & Body Works has higher revenue and earnings than Uxin. Uxin is trading at a lower price-to-earnings ratio than Bath & Body Works, indicating that it is currently the more affordable of the two stocks.
Summary
Bath & Body Works beats Uxin on 11 of the 14 factors compared between the two stocks.
About Bath & Body Works
Bath & Body Works, Inc. is a specialty retailer focused on personal care and home fragrance products. Its offerings include body lotions, soaps, fragrances, hand sanitizers, candles and other home-fragrance items, sold under the Bath & Body Works and White Barn brands. The company serves customers through its stores and e-commerce platform in the United States and Canada, as well as through international franchise, license and wholesale partners. Bath & Body Works traces its roots to a store launched in 1990.
About Uxin
Uxin Limited operates a used-car retail business in China, combining an online platform with physical retail locations. Its platform lets customers browse used vehicles and access information to support their purchasing decisions. The company’s services include vehicle inspection and retail sales, along with support for transactions and delivery. Uxin has also offered financing options to customers as part of the vehicle-purchase process. Founded in 2011, Uxin initially built its business around online used-car services and later expanded into direct retail.
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.
